Loading...
Willow Biosciences Inc.
WLLW.TO•TSX
HealthcareDrug Manufacturers - Specialty & Generic
$0.03
$-0.01(-14.29%)
Willow Biosciences Inc. (WLLW.TO) Stock Overview
Explore Willow Biosciences Inc.’s financial performance, market position, analyst ratings, and future outlook.
Revenue Growth
297.78%
↑ 297.78%
Profit Growth
$-0.05
↑ 52.50%
EPS Growth
$-0.05
↑ 50.00%
Operating Margin
-128.51%
↑ 54.55%
ROE
-2099.75%
↑ 52.50%
Dividend Yield
0.00%
Analyst Recommendations data is not available for WLLW.TOAnalyst Recommendations details for WLLW.TO are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada.
CEO
Mr. Travis Doupe
Employees
19
Headquarters
202, 1201-5th Street SW, Calgary, AB
Founded
2021